Literature DB >> 28552531

A causal relationship between the neurotherapeutic effects of miR182/7a and decreased expression of PRDM5.

Weiqi Ling1, Xu Xu1, Jinbo Liu2.   

Abstract

BACKGROUND: Spinal cord injury (SCI) is terrible damage resulting in the deficiencies and necrosis of neurology and causes infinite inconvenience to sufferers. The therapy of SCI still meets a larger number of problems. Therefore, the underlying mechanism and novel therapy of acute SCI (ASCI) are urgent to explore.
MATERIALS AND METHODS: The SCI model was established in rats. The expression of miR-182/miR-7a and PRDM5 at mRNA level was detected by quantitative real-time PCR and the protein expression of PRDM5 and c-caspase 3 was assessed by western blotting assays. The apoptosis of spinal cord neurons (SCN) was assessed on flow cytometry. The transfection of cells was performed by Lipofectamine 2000 kit. The relationship between PRDM5 and miR-182/miR-7a was examined by Luciferase assay.
RESULTS: The expression of PRDM5 was up-regulated at either mRNA (2.212 folds) or protein level after SCI in rats, and knockdown of PRDM5 in SCN declined the c-caspase3 expression. In addition, the expression of miR-182 and miR-7a was decreased by 44.6% and 39.3% after SCI in rats. Moreover, the expression of miR-182 and miR-7a were negatively correlated with the level of PRDM5 expression, and the expression of PRDM5 was inhibited due to the increase of miR-182 and/or miR-7a expression. Moreover, both miR-182 and miR-7a could regulate PRDM5 to control SCN apoptosis. According to the BBB score increased 2 folds, the intrathecal injection of miR-182 and miR-7a improved the neurological function of rats.
CONCLUSION: Inhibition of PRDM5 which was apparently negative correlation with miR-182 and miR-7a could suppress the neurons apoptosis to attenuate acute spinal cord injury in rats.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute spinal cord injury; Apoptosis of SCN; MiR-182 and miR-7a; PRDM5

Mesh:

Substances:

Year:  2017        PMID: 28552531     DOI: 10.1016/j.bbrc.2017.05.141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Knockdown of lncRNA BDNF-AS suppresses neuronal cell apoptosis via downregulating miR-130b-5p target gene PRDM5 in acute spinal cord injury.

Authors:  Huafeng Zhang; Dongzhe Li; Yi Zhang; Jianqiang Li; Shengli Ma; Jianwei Zhang; Yuanyuan Xiong; Wengang Wang; Ning Li; Lei Xia
Journal:  RNA Biol       Date:  2018-09-10       Impact factor: 4.652

2.  LncRNA DGCR5 suppresses neuronal apoptosis to improve acute spinal cord injury through targeting PRDM5.

Authors:  Huafeng Zhang; Wengang Wang; Ning Li; Peng Li; Ming Liu; Junwei Pan; Dan Wang; Junwei Li; Yuanyuan Xiong; Lei Xia
Journal:  Cell Cycle       Date:  2018-09-11       Impact factor: 4.534

3.  LncRNA CASC9 attenuates lactate dehydrogenase-mediated oxidative stress and inflammation in spinal cord injury via sponging miR-383-5p.

Authors:  Congjin Guan; Yi Wang
Journal:  Inflammation       Date:  2021-01-12       Impact factor: 4.092

4.  Hearing impairment due to Mir183/96/182 mutations suggests both loss and gain of function effects.

Authors:  Morag A Lewis; Francesca Di Domenico; Neil J Ingham; Haydn M Prosser; Karen P Steel
Journal:  Dis Model Mech       Date:  2020-12-14       Impact factor: 5.758

Review 5.  Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors).

Authors:  Paweł Leszczyński; Magdalena Śmiech; Emil Parvanov; Chisato Watanabe; Ken-Ichi Mizutani; Hiroaki Taniguchi
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

6.  MicroRNA-182 improves spinal cord injury in mice by modulating apoptosis and the inflammatory response via IKKβ/NF-κB.

Authors:  Min Fei; Zheng Li; Yuanwu Cao; Chang Jiang; Haodong Lin; Zixian Chen
Journal:  Lab Invest       Date:  2021-05-31       Impact factor: 5.662

7.  miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression.

Authors:  Chengxin Ma; Dasa He; Pu Tian; Yuan Wang; Yunfei He; Qiuyao Wu; Zhenchang Jia; Xue Zhang; Peiyuan Zhang; Hao Ying; Zi-Bing Jin; Guohong Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.